Click here to get in touch with the Profounda Team.
Toll Free: (407) 270-7790
CNN report on Survivor of Brain Eating Amoeba
Patient survives Brain Eating Amoeba
Profounda OutLicenses right to development product
Company formation complete
Here we come 2023!
Generic to Arestin Microspheres by Bausch Health (Orapharma) receives Competitive Generic Therapy De
DOG AND HUMANS GET GREAT RESULTS
Sales exceed $2 Million for first year of Profounda's Commercial Presence in the USA
Orphan drug status approval for Acanthamoeba Keratitis received by Profounda for Miltefosine
Profounda Inc. receives FDA orphan-drug designation for the Treatment of Primary Amebic Meningoencep
Profounda working with local Health Officials in fight to save patients life.
Profounda Licensed in Florida